To study the effect of Dhatryadi churna in the management of Diabetes Mellitus type 2

Single blind randomised controlled clinical trial on dhatryadi churna in the management of prameha with special reference to Diabetes Mellitus Type 2 - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101512

Enrollment

160

Registered

2026-01-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having HbA1c 6.4 to 7.5 % Patients with fasting blood sugar between 126 to 200 mg / dl & postprandial blood sugar between 200 to 300 mg/dl.

Exclusion criteria

Exclusion criteria: Patients with hypoglycemic coma ketoacidosis and related complications history of complications infections Patients with known chronic diabetic complications Retinopathy Nephropathy Peripheral neuropathy postural hypotension ulceration Pregnant and lactating women. Patients suffering from major systemic diseases TB HIV Carcinoma uncontrolled HTN IHD CAD

Design outcomes

Primary

Measure	Time frame
efficacy of 2gm of Dhatryadi Churna on Blood Sugar Level HbA1c and urine analysis of patients of DM type 2 Timepoint: at baseline, 4weeks, 8weeks, 12 weeks	—

Secondary

Measure	Time frame
efficacy of 2gm of Dhatryadi churna subjective parameters Adverse Reaction if anyTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Dipti Dattatray Kalangutkar

Yashwant Ayurvedic College and Post Graduate Training and Research Center Kodoli Maharasthra Univeristy of Health Science NAshik

suryakiran_wagh@rediffmail.com9822846910

Outcome results